Evaxion Biotech A/S

EVAX

US29970R2040

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 02:00:01 29/05/2024 am IST			5-day change	1st Jan Change
3.83 ^USD	-5.20%		+7.28%	-44.14%

28/05	Earnings Flash (EVAX) EVAXION BIOTECH Reports Q1 Revenue $51,000	MT
28/05	Evaxion Biotech A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evaxion Biotech A/S Announces Resignation of Per Norlén, M.D., Phd. as Chief Executive Officer

August 29, 2023 at 06:53 pm IST

Evaxion Biotech A/S announced that Per Norlén, M.D., PhD., will resign from his current position as the Company?s Chief Executive Officer.

Latest news about Evaxion Biotech A/S

Earnings Flash (EVAX) EVAXION BIOTECH Reports Q1 Revenue $51,000	28/05	MT
Evaxion Biotech A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	28/05	CI
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	24/05	MT
Evaxion Biotech Plans to Unveil 'Positive' Data From Phase 2 Study of Advanced Melanoma Combination Treatment	24/05	MT
Evaxion Biotech A/S to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024	24/05	CI
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	24/05	MT
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	22/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	21/05	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading	15/05	MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher	13/05	MT
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	06/05	MT
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	03/05	MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	02/05	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading	01/05	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	29/04	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	26/04	MT
Evaxion Biotech A/S Elects Lars Staal Wegner as A New Board Member	26/04	CI
Evaxion Announces Phase 2 Clinical Trial Update	17/04	CI
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	11/04	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	09/04	MT
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	08/04	MT
Certain Warrants of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04	CI
Certain American Depositary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04	CI
Certain Ordinary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04	CI
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05/04	MT

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Sector

Biotechnology & Medical Research

Calendar

30/05/2024 - Nordic Digital Science & Innovation Day

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.83 USD

Average target price

11.75 USD

Spread / Average Target

+206.79%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EVAXION BIOTECH A/S	-44.14%	20.72M
MODERNA, INC.	+54.05%	58.71B
IQVIA HOLDINGS INC.	-2.02%	41.31B
LONZA GROUP AG	+40.01%	39.2B
CELLTRION, INC.	-10.22%	27.4B
ICON PUBLIC LIMITED COMPANY	+13.42%	26.55B
ALNYLAM PHARMACEUTICALS, INC.	-21.60%	18.98B
BIO-TECHNE CORPORATION	+2.89%	12.51B
UNITED THERAPEUTICS CORPORATION	+22.40%	11.94B
MEDPACE HOLDINGS, INC.	+27.49%	12.08B

Other Biotechnology & Medical Research